Histones, protamine, and polylysine but not poly(E:K) enhance transfection efficiency

International Journal of Oncology

Volumn 10, Issue 2, 1997, Pages 317-322

  Boulikas, Teni ^a   Martin, Francis ^b  

^a Inst of Molecular Medical Sciences   (United States)

^b ALZA CORPORATION   (United States)

Author keywords

cationic liposomes; cytomegalovirus promoter; gene therapy; histone; light scattering; luciferase gene; nuclear import; protamine; transfection

Indexed keywords

HISTONE; LIPOSOME; LUCIFERASE; POLYLYSINE; POLYMER; PROTAMINE;

ARTICLE; CELL CULTURE; DNA PROTEIN COMPLEX; ENZYME ACTIVITY; ERYTHROLEUKEMIA; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROTEIN DNA BINDING;

EID: 0031042832     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.2.317     Document Type: Article

References (48)

1. Anderson WF: Human gene therapy. Science 256: 808-813, 1992.
2. Boulikas T: Cancer gene therapy and immunotherapy. Int J Oncol 9: 941-954, 1996.
3. Boulikas T: Gene therapy to human diseases: ex vivo and in vivo studies. In J Oncol 9: 1239-1251, 1996.
4. Boulikas T: Gene therapy of prostate cancer: p53, suicidal genes, and other targets. Anticancer Res (In press).
5. Roth JA: Clinical protocol. Modification of tumor suppressor gene expression and induction of apoptosis in non-small cell lung cancer (NSCLC) with an adcnovirus vector expressing wild-type p53 and cisplatin. Hum Gene Ther 7: 1013-1030, 1996.
6. Isner JM, Walsh K, Rosenfield K, Schainfeld R, Asahara T, Hogan K and Pieczek A: Clinical protocol. Arterial gene therapy for restenosis. Hum Gene Ther 7: 989-1011, 1996.
7. Chang AE, Sondak VK, Bishop DK, Nickoloff BJ, Mulligan RC and Mule JJ: Clinical protocol. Adoptive immunotherapy of cancer with activated lymph node cells primed in vivo with autologous tumor cells transduced with the GM-CSF gene. Hum Gene Ther 7: 773-792, 1996.
8. Gregoriadis G and Neerunjun ED: Homing of liposomes to target cells. Biochem Biophys Res Commun 65: 537-544, 1975.
9. Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, Lee K-D, Woodle MC, Lasic DD, Redemann C and Martin FJ: Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 88: 11460-11464, 1991.
10. Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, Martin F, Huang A and Barenholz Y: Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54: 987-992, 1994.
11. Lasic D and Martin F (eds): 'Stealth liposomes' CRC Press Boca Raton, Florida, pp1-289, 1995.
12. Ahmad I, Longenecker M, Samuel J and Allen TM: Antibody-targeted delivery of doxorubicin entrapped in Sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res 53: 1484-1488, 1993.
13. HER2 immunoliposomes for cancer therapy. Proc Natl Acad Sci USA 92: 1327-1331, 1995.
14. Lee RJ, Low PS: Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1233: 134-144, 1995.
15. Behr J-P: Gene transfer with synthetic cationic amphiphiles; prospects for gene therapy. Bioconj Chem 5: 382-389, 1994.
16. Lasic D and Papahadjopoulos D: Liposomes revisited. Science 267: 1275-1276, 1995.
17. Ledley FD: Nonviral gene therapy: The promise of genes as pharmaceutical products. Hum Gene Ther 6: 1129-1144, 1995.
18. Boulikas T: Liposome DNA delivery and uptake by cells. Oncol Rep 3: 989-995, 1996.
19. Boulikas T: Electrophoretic separation of histones and HMG proteins on acid-urea-Triton gels. Anal Biochem 199: 379-386, 1985.
20. Curiel DT, Agarwal S, Wagner E and Cotten M: Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc Natl Acad Sci USA 88: 8850-8854, 1991.
21. Wagner E, Cotten M, Foisner R, Birnstiel ML: Transferrin-polycation-DNA complexes: The effect of polycations on the structure of the complex and DNA delivery to cells. Proc Natl Acad Sci USA 88: 4255-4259, 1991.
22. Wagner E, Plank C, Zatloukal K, Cotten M and Birnstiel ML: Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA 89: 7934-7938, 1992.
23. Wagner E, Zatloukal K, Cotten M, Kirlappos H, Mechtler K, Curiel DT and Birnstiel ML: Coupling of adenovirus to tranferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA 89: 6099-6103, 1992.
24. Walter A, Steer CJ, Blumethal R: Polylysincs induces pH-dependent fusion of acidic phospholipid vesicles: A model for polycation-induced fusion. Biochim Biophys Acta 861: 319-330, 1986.
25. Boulikas T: Nuclear localization signals (NLS). Crit Rev Eukar Gene Expression 3: 193-227, 1993.
26. Boulikas T: Putative nuclear localization signals (NLS) in protein transcription factors. J Cell Biochem 55: 32-58, 1994.
27. Boulikas T: Nuclear import of protein kinases and cyclins. J Cell Biochem 60: 61-82, 1996.
28. White EM, Allis CD, Goldfarb DS, Srivastva A, Weir JW and Gorovsky MA: Nucleus-specific and temporally restricted localization of proteins in Tetrahymena macronuclei and micronuclei. J Cell Biol 109: 1983-1992, 1989.
29. Ryser HJ-P and Hancock R: Histones and basic polyamino acids stimulate the uptake of albumin by tumor cells in culture. Science 150: 501-503, 1965.
30. Kaneda Y, Iwai K and Uchida T: Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243: 375-378, 1989.
31. Kato K, Nakanishi M, Kaneda Y, Uchida T, Okada Y: Expression of hepatitis B virus surface antigen in adult rat liver. J Biol Chem 266: 3361-3364, 1991.
32. Seibel P, Trappe J, Villani G, Klopstock T, Papa S and Reichman H: Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases. Nucleic Acids Res 23: 10-17, 1995.
33. Fritz JD, Herweijer H, Zhang G and Wolff JA: Gene transfer into mammalian cells using histone-condensed plasmid DNA. Hum Gene Ther 7: 1395-1404, 1996.
34. Boulikas T: Nuclear localization signal peptides for the import of plasmid DNA in gene therapy. In J Oncol (In press)
35. Görlich D, Prehn S, Laskey RA, Hartmann E: Isolation of a protein that is essential for the first step of nuclear protein import. Cell 79: 767-778, 1994.
36. Rexach M, Blobel G: Protein import into nuclei: association and dissociation reactions involving transport substrate, transport factors, and nucleoporins. Cell 83: 683-692, 1995.
37. Nehrbass U, Blobel G: Role of the nuclear transport factor p10 in nuclear import. Science 272: 120-122, 1996.
38. Moroianu J, Blobel G, Radu A: Nuclear protein import: Ran-GTP dissociates the karyopherin αβ heterodimer by displacing a from an overlapping binding site on β. Proc Natl Acad Sci USA 93: 7059-7062, 1996.
39. Panté N and Aebi U: Sequential binding of import ligands to distinct nucleopore regions during their nuclear import. Science 273: 1729-1732, 1996.
40. Peifer M, Berg S, Reynolds AB: Letter to the Editor. A repeating amino acid motif shared by proteins with diverse cellular roles. Cell 76: 789-791, 1994.
41. Thierry AR, Lunardi-Iskandar Y, Bryant JL, Rabinovitch P, Gallo RC and Mahan LC: Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proc Natl Acad Sci USA 92: 9742-9746, 1995.
42. Gassmann M, Donoho G and Berg P: Maintenance of an extrachromosomal plasmid vector in mouse embryonic stem cells. Proc Natl Acad Sci USA 92: 1292-1296, 1995.
43. Boulikas T: Chromatin domains and prediction of MAR sequences. Int Rev Cytol 162A: 279-388, 1995.
44. Bode J, Schlake T, Ríos-Ramírez M, Mielke C, Stengert M, Kay V, Klehr-Wirth D: Scaffold/matrix-attached regions: structural properties creating transcriptionally active loci. Int Rev Cytol 162A: 389-454, 1995.
45. Bode J, Kohwi Y, Dickinson L, Joh T, Klehr D, Mielke C and Kohwi-Shigematsu T: Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science 255: 195-197, 1992.
46. Spandidos DA: A unified theory for the development of cancer. Biosci Rep 6: 691-708, 1986.
47. Anders F, Schartl M, Barnekow A and Anders A: Xiphophorus as an in vivo model for studies on normal and defective control of oncogenes. Adv Cancer Res 42: 191-275, 1984.
48. Chen Y, Chen C-F, Riley DJ, Allred DC, Chen P-L Von Hoff D, Osborne CK and Lee W-H: Aberrant subcellular localization of BRCA1 in breast cancer. Science 270: 789-791, 1995.